The number of people with susceptibility test result for rifampicin in Qatar

Qatar: The number of people with susceptibility test result for rifampicin was 411 in 2021. ▲ Rising

Latest (2021)
411
Change on year
up 9.9%
World rank
84th
of 155 countries
All-time high
411
in 2021
All-time low
223
in 2019
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Qatar, 2017–2021

01002003004002017201920212017: 3352018: 3352019: 2232020: 3742021: 411

Source: World Health Organization, Global Health Observatory.

Analysis

Qatar recorded 411 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.

Compared with earlier readings it is up 9.9% on the previous year and up 22.7% over five years.

That places Qatar 84th out of 155 countries with data for 2021, putting it in the middle of the range.

The number of people with susceptibility test result for rifampicin in Qatar, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in Qatar, 2017 to 2021.
Year Value Change
2017 335
2018 335 +0.0%
2019 223 -33.4%
2020 374 +67.7%
2021 411 +9.9%

Qatar compared with similar countries

  • Qatar's 411 is above the median for high income countries, which is 142, 2.9× the median. (61 countries reporting)
  • Qatar's 411 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 406, 1.0× the median. (16 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 297.67 223 335 3
2020s 392.5 374 411 2

Countries ranked near Qatar

  1. 81 Portugal 482 compare
  2. 82 Lithuania 465 compare
  3. 83 Bhutan 419 compare
  4. 85 Kuwait 401 compare
  5. 86 Belgium 377 compare
  6. 87 El Salvador 316 compare

See the full ranking of 157 places →

More health data for Qatar

All data for Qatar →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Qatar?
The number of people with susceptibility test result for rifampicin in Qatar was 411 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Qatar?
The highest recorded value was 411 in 2021.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Qatar?
The lowest recorded value was 223 in 2019.
How does Qatar rank for the number of people with susceptibility test result for rifampicin?
Qatar ranks 84th out of 155 countries with data for 2021.
Where does this Qatar data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Qatar. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 15 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/qatar/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/qatar/">The number of people with susceptibility test result for rifampicin in Qatar</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed